Speakers
Kirstie Cole brings 25 years of strategic sales and leadership experience to Bausch + Lomb. Known for driving consistent growth and building high-performing teams, Kirstie…
Read MoreDr. Friedman oversees a family office that focuses on private companies in the biotechnology and pharmaceutical space, with an emphasis on platform technologies, oncology, neurodegenerative…
Read MoreDr. Myung is an Associate Professor of Ophthalmology at the Byers Eye Institute at Stanford and, by courtesy, of Chemical Engineering. He is a board-certified…
Read MoreNatalie Afshari, MD, FACS, is Chief of Cornea and Refractive Surgery and is accomplished as a clinician, surgeon, and research scientist. She received her medical…
Read MoreDr. Michael Abramoff, MD, PhD, (FARVO) is the Robert C. Watzke, MD Professor of Ophthalmology and Visual Sciences at the University of Iowa, with a…
Read MoreDr. Jeffrey Goldberg is Professor and Chair of Ophthalmology and Director of the Byers Eye Institute at Stanford University. His focus is on regenerative medicine…
Read MoreMartin (Marty) Waters is a corporate and securities partner in the San Diego office. He is a founding partner of the firm’s San Diego office…
Read MoreRebecca Kammer is the Vice President of Worldwide Clinical and Medical Affairs at Samsara Vision, where she leads global clinical efforts for a groundbreaking intraocular…
Read MoreShannon Spock is a seasoned professional with over 20 years of experience in ophthalmology and eye care. During her tenure at Alcon, she has held…
Read MoreMichael Friedman, based in San Rafael, CA, US, is currently a Executive Director Global Medical Affairs Strategy at Apellis Pharmaceuticals. Michael Friedman brings experience from…
Read MoreMark Barakat received his undergraduate degree in Computer Science from Duke University and his medical degree from the University of Pennsylvania. He completed residency training…
Read MoreDave LeCause is a highly respected biopharmaceutical executive with extensive leadership experience across all areas of commercialization and multiple therapeutic categories, technologies and business models.…
Read MoreSUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.